Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica I Hoell

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Genes, Chromosomes & Cancer|July 22, 2014
Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL-BFM protocolsMarius Rohde, Julia Richter, Matthias Schlesner, et al.
NPJ Vaccines|February 5, 2024
SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 conditionClaudia Fischer, Edith Willscher, Lisa Paschold, et al.
Leukemia|September 1, 2021
YBX1 mediates translation of oncogenic transcripts to control cell competition in AMLFlorian Perner, Tina M Schnoeder, Yijun Xiong, et al.
British Journal of Haematology|December 2, 2017
Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trialMichaela Kuhlen, Andre M Willasch, Jean-Hugues Dalle, et al.
Gut|August 15, 2019
Fragile X mental retardation protein protects against tumour necrosis factor-mediated cell death and liver injuryYuan Zhuang, Haifeng C Xu, Prashant V Shinde, et al.
Blood|May 5, 2023
A noncanonical enzymatic function of PIWIL4 maintains genomic integrity and leukemic growth in AMLShiva Bamezai, Alex Jose Pulikkottil, Tribhuwan Yadav, et al.
Blood Advances|October 25, 2019
Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targetsJessica I Hoell, Sebastian Ginzel, Michaela Kuhlen, et al.
Journal of Virology|November 17, 2017
Tumor Necrosis Factor-Mediated Survival of CD169<sup>+</sup> Cells Promotes Immune Activation during Vesicular Stomatitis Virus InfectionPrashant V Shinde, Haifeng C Xu, Sathish Kumar Maney, et al.
Genes, Chromosomes & Cancer|January 23, 2025
MicroRNA Expression in High-Grade B-Cell Lymphoma With 11q AberrationGioia Di Stefano, Anja Fischer, Emil Chteinberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2015
MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cellsGero Doose, Andrea Haake, Stephan H Bernhart, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Genes, Chromosomes & Cancer|July 22, 2014
Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL-BFM protocolsMarius Rohde, Julia Richter, Matthias Schlesner, et al.
NPJ Vaccines|February 5, 2024
SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 conditionClaudia Fischer, Edith Willscher, Lisa Paschold, et al.
Leukemia|September 1, 2021
YBX1 mediates translation of oncogenic transcripts to control cell competition in AMLFlorian Perner, Tina M Schnoeder, Yijun Xiong, et al.
British Journal of Haematology|December 2, 2017
Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trialMichaela Kuhlen, Andre M Willasch, Jean-Hugues Dalle, et al.
Gut|August 15, 2019
Fragile X mental retardation protein protects against tumour necrosis factor-mediated cell death and liver injuryYuan Zhuang, Haifeng C Xu, Prashant V Shinde, et al.
Blood|May 5, 2023
A noncanonical enzymatic function of PIWIL4 maintains genomic integrity and leukemic growth in AMLShiva Bamezai, Alex Jose Pulikkottil, Tribhuwan Yadav, et al.
Blood Advances|October 25, 2019
Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targetsJessica I Hoell, Sebastian Ginzel, Michaela Kuhlen, et al.
Journal of Virology|November 17, 2017
Tumor Necrosis Factor-Mediated Survival of CD169<sup>+</sup> Cells Promotes Immune Activation during Vesicular Stomatitis Virus InfectionPrashant V Shinde, Haifeng C Xu, Sathish Kumar Maney, et al.
Genes, Chromosomes & Cancer|January 23, 2025
MicroRNA Expression in High-Grade B-Cell Lymphoma With 11q AberrationGioia Di Stefano, Anja Fischer, Emil Chteinberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2015
MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cellsGero Doose, Andrea Haake, Stephan H Bernhart, et al.
Pageof 5